StockClub

MIST

MISTMilestone Pharmaceuticals Inc.$ --
Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.

MIST

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY +Infinity%
Operating Income
-24M USD
YoY -15.8%
Net Income
-26M USD
YoY -25.6%
EPS
-0.2$
YoY +35.5%

Revenue

$238,000
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$1.5M
$1.5M
Q4
FY2026 Q1$238,000
$238,000
Q1
Actual
+$238,000 (-)

Net Income

$-26.1M
FY2024 Q2$-19.7M
$-19.7M
Q2
FY2024 Q3$-29.2M
$-29.2M
Q3
FY2024 Q4$-41.5M
$-41.5M
Q4
FY2025 Q1$-20.8M
$-20.8M
Q1
FY2025 Q2$-33.7M
$-33.7M
Q2
FY2025 Q3$-45.6M
$-45.6M
Q3
FY2025 Q4$-63.1M
$-63.1M
Q4
FY2026 Q1$-26.1M
$-26.1M
Q1
Actual
$-5.3M (-25.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021IN-LINE
Actual:$15M
Est:$15M
FY2021IN-LINE
$15M
FY2022BEAT
Actual:$5M
Est:$2M
FY2022BEAT
$5M
FY2023IN-LINE
Actual:$1M
Est:$1M
FY2023IN-LINE
$1M
FY2024MISS
Actual:$0
Est:$1.8M
FY2024MISS
$0
FY2025MISS
Actual:$1.5M
Est:$4.3M
FY2025MISS
$1.5M

Analyst Estimates